Extracorporeal membrane oxygenation for tuberculosis-related acute respiratory distress syndrome: An international multicentre retrospective cohort study
- PMID: 39385275
- PMCID: PMC11465915
- DOI: 10.1186/s13054-024-05110-y
Extracorporeal membrane oxygenation for tuberculosis-related acute respiratory distress syndrome: An international multicentre retrospective cohort study
Abstract
Objective: To report the outcomes of patients with severe tuberculosis (TB)-related acute respiratory distress syndrome (ARDS) on extracorporeal membrane oxygenation (ECMO), including predictors of 90-day mortality and associated complications.
Methods: An international multicenter retrospective study was conducted in 20 ECMO centers across 13 countries between 2002 and 2022.
Results: We collected demographic data, clinical details, ECMO-related complications, and 90-day survival status for 79 patients (median APACHE II score of 20 [25th to 75th percentile, 16 to 28], median age 39 [28 to 48] years, PaO2/FiO2 ratio of 69 [55 to 82] mmHg before ECMO) who met the inclusion criteria. Thoracic computed tomography showed that 61 patients (77%) had cavitary TB, while 18 patients (23%) had miliary TB. ECMO-related complications included major bleeding (23%), ventilator-associated pneumonia (41%), and bloodstream infections (32%). The overall 90-day survival rate was 51%, with a median ECMO duration of 20 days [10 to 34] and a median ICU stay of 42 days [24 to 65]. Among patients on VV ECMO, those with miliary TB had a higher 90-day survival rate than those with cavitary TB (90-day survival rates of 81% vs. 46%, respectively; log-rank P = 0.02). Multivariable analyses identified older age, drug-resistant TB, and pre-ECMO SOFA scores as independent predictors of 90-day mortality.
Conclusion: The use of ECMO for TB-related ARDS appears to be justifiable. Patients with miliary TB have a much better prognosis compared to those with cavitary TB on VV ECMO.
Keywords: Acute respiratory distress syndrome; Extracorporeal membrane oxygenation; Miliary; Outcome; Tuberculosis.
© 2024. The Author(s).
Conflict of interest statement
Dr. Peter Schellongowski reports grants from the European Commission and the European Society of Intensive Care Medicine, and lecture fees from Fresenius Medical. Dr Romain Sonneville reports grants from the French Ministry of Health and LFB. Dr. Saad Nseir reports MSD, Pfizer, Biomérieux, Fisher and Paykel, Medtronic, and Shionogi lecture fees. Dr. Matthieu Schmidt reports lecture fees from Getinge, Dräger, Baxter, and Fresenius Medical reports lecture fees. Dr. Alain Combes reports grants from Getinge, and personal fees from Getinge, Baxter, and Xenios outside the submitted work. No other disclosures were reported.
Figures



References
-
- Hraiech S, Pauly V, Orleans V, Auquier P, Boyer L, Papazian L, et al. Undocumented migrants in French intensive care units in 2011–2018: retrospective nationwide study. Intensive Care Med. 2022;48:290–9. - PubMed
-
- Combes A, Brodie D, Bartlett R, Brochard L, Brower R, Conrad S, et al. Position paper for the organization of extracorporeal membrane oxygenation programs for acute respiratory failure in adult patients. Am J Respir Crit Care Med. 2014;190:488–96. - PubMed
-
- Tonna JE, Abrams D, Brodie D, Greenwood JC, Rubio Mateo-Sidron JA, Usman A, et al. Management of adult patients supported with venovenous extracorporeal membrane oxygenation (VV ECMO): guideline from the extracorporeal life support organization (ELSO). ASAIO J Am Soc Artif Intern Organs. 1992;2021(67):601–10. - PMC - PubMed
-
- Combes A, Hajage D, Capellier G, Demoule A, Lavoué S, Guervilly C, et al. Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome. N Engl J Med. 2018;378:1965–75. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous